Colgate-Palmolive (CL) has consistently exhibited robust performance despite several market challenges. The company's shares have recently been the subject of multiple transactions, both acquisitions, and sell-offs by institutional investors, indicating a continued interest among financial powerhouses. Q4 FY25 and full-year 2025 results outperformed estimates, pushing share prices up and justifying analysts' bullish stance. The company also took a $1.0B one-off charge, proving its ability to withstand significant financial blows. Multiple institutions, including Morgan Stanley, Wells Fargo, and Citigroup, have raised their price targets for CL, suggesting continued confidence in Colgate’s future prospects. Even amidst consumer uncertainty, its international sales shone, and its upcoming dividend has sparked interest. The company also declared a long-term growth strategy starting 2030. However, insiders, including the CEO, sold large volumes of their company shares, a move potentially construed as a lack of faith in the company’s future trajectory. Regardless, analysts still recommend Colgate-Palmolive as a strong growth stock, and predict the stock price to rise.
Colgate-Palmolive Company CL News Analytics from Sun, 13 Jul 2025 07:00:00 GMT to Sat, 07 Feb 2026 15:08:30 GMT -
Rating 8
- Innovation 5
- Information 7
- Rumor -5
